TY - JOUR
T1 - Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II
AU - Barinka, Cyril
AU - Rinnová, Markéta
AU - Šácha, Pavel
AU - Rojas, Camilo
AU - Majer, Pavel
AU - Slusher, Barbara S.
AU - Konvalinka, Jan
PY - 2002/2
Y1 - 2002/2
N2 - Glutamate carboxypeptidase II (GCPII, EC 3.4.17.21) is a membrane peptidase expressed in a number of tissues such as kidney, prostate and brain. The brain form of GCPII (also known as NAALADase) cleaves N-acetyl-aspartyl glutamate to yield free glutamate. Animal model experiments show that inhibition of GCPII prevents neuronal cell death during experimental ischaemia. GCPII thus represents an important target for the treatment of neuronal damage caused by excess glutamate. In this paper we report expression of an extracellular portion of human glutamate carboxypeptidase II (amino acids 44-750) in Drosophila Schneider's cells and its purification to homogeneity. A novel assay for hydrolytic activity of recombinant human GCPII (rhGCPII), based on fluorimetric detection of released alpha-amino groups was established, and used for its enzymological characterization. rhGCPII does not show dipeptidylpeptidase IV-like activity assigned to the native form of the enzyme previously. Using a complete set of protected dipeptides, substrate specificity of rhGCPII was elucidated. In addition to the previously described substrates, four novel compounds, Ac-Glu-Met, Ac-Asp-Met and, surprisingly, Ac-Ala-Glu and Ac-Ala-Met were identified as substrates for GCPII, and their respective kinetic constants determined. The glycosylation of rhGCPII was found indispensable for the enzymatic activity.
AB - Glutamate carboxypeptidase II (GCPII, EC 3.4.17.21) is a membrane peptidase expressed in a number of tissues such as kidney, prostate and brain. The brain form of GCPII (also known as NAALADase) cleaves N-acetyl-aspartyl glutamate to yield free glutamate. Animal model experiments show that inhibition of GCPII prevents neuronal cell death during experimental ischaemia. GCPII thus represents an important target for the treatment of neuronal damage caused by excess glutamate. In this paper we report expression of an extracellular portion of human glutamate carboxypeptidase II (amino acids 44-750) in Drosophila Schneider's cells and its purification to homogeneity. A novel assay for hydrolytic activity of recombinant human GCPII (rhGCPII), based on fluorimetric detection of released alpha-amino groups was established, and used for its enzymological characterization. rhGCPII does not show dipeptidylpeptidase IV-like activity assigned to the native form of the enzyme previously. Using a complete set of protected dipeptides, substrate specificity of rhGCPII was elucidated. In addition to the previously described substrates, four novel compounds, Ac-Glu-Met, Ac-Asp-Met and, surprisingly, Ac-Ala-Glu and Ac-Ala-Met were identified as substrates for GCPII, and their respective kinetic constants determined. The glycosylation of rhGCPII was found indispensable for the enzymatic activity.
KW - Enzyme glycosylation
KW - Glutamate carboxypeptidase II
KW - NAALADase
KW - Neuroprotection
KW - Zinc metallopeptidase
UR - http://www.scopus.com/inward/record.url?scp=0036488137&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036488137&partnerID=8YFLogxK
U2 - 10.1046/j.0022-3042.2001.00715.x
DO - 10.1046/j.0022-3042.2001.00715.x
M3 - Article
C2 - 11905994
AN - SCOPUS:0036488137
SN - 0022-3042
VL - 80
SP - 477
EP - 487
JO - Journal of Neurochemistry
JF - Journal of Neurochemistry
IS - 3
ER -